Angiotensin 1-7
Angiotensin 1-7 is a pharmaceutical drug with 8 clinical trials. Currently 1 active trials ongoing.
Success Metrics
Phase Distribution
Phase Distribution
6
Early Stage
2
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
0.0%
0 of 3 finished
100.0%
3 ended early
1
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Safety and Efficacy of Angiotensin (1-7) in Persons With Moderate to Severe Traumatic Brain Injury
Angiotensin-(1-7) in Peripheral Arterial Disease
Cardiovascular Effects of Angiotensin (1-7) in Essential Hypertension
Biomarker Study: Heart Failure Patients at Risk
Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial
Clinical Trials (8)
Safety and Efficacy of Angiotensin (1-7) in Persons With Moderate to Severe Traumatic Brain Injury
Angiotensin-(1-7) in Peripheral Arterial Disease
Cardiovascular Effects of Angiotensin (1-7) in Essential Hypertension
Biomarker Study: Heart Failure Patients at Risk
Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial
Angiotensin 1-7 as a Therapy in the Treatment of COVID-19
Acute Effect of Agiotensin-(1-7) in Healthy and Hypertensive Subjects
Safety Study of TXA127 to Elevate CD4+ T-Lymphocyte Counts in HIV-Infected Patients on Stable HAART Therapy
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8